These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 15041269)
1. The epidemiological night where all patients are black: will pharmacogenetics shed some light? de Gaetano G; Cerletti C; Iacoviello L; Donati MB Thromb Res; 2003; 112(5-6):273-4. PubMed ID: 15041269 [No Abstract] [Full Text] [Related]
2. Pharmacogenetics: using DNA to optimize drug therapy. Lanfear DE; McLeod HL Am Fam Physician; 2007 Oct; 76(8):1179-82. PubMed ID: 17990842 [TBL] [Abstract][Full Text] [Related]
3. [P-glycoprotein--a pump of significance for drug response]. Molden E Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2921-3. PubMed ID: 15550968 [No Abstract] [Full Text] [Related]
4. [Pharmacogenomics: way to individual therapy]. Piruzian AL Eksp Klin Farmakol; 2005; 68(5):59-67. PubMed ID: 16277215 [TBL] [Abstract][Full Text] [Related]
6. Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al. Riksen NP; Rongen GA; Smits P; van Riel P; Barrera P Arthritis Rheum; 2007 Feb; 56(2):694; author reply 694-5. PubMed ID: 17265507 [No Abstract] [Full Text] [Related]
7. Pharmacogenetics. David SP Prim Care; 2004 Sep; 31(3):543-59, ix. PubMed ID: 15331247 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics: bench to bedside. Weinshilboum R; Wang L Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384 [TBL] [Abstract][Full Text] [Related]
9. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions. Wang L; Weinshilboum R Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163 [TBL] [Abstract][Full Text] [Related]
10. Polymorphism at position -308 of the tumour necrosis factor alpha gene and rheumatoid arthritis pharmacogenetics. Fonseca JE; Carvalho T; Cruz M; Nero P; Sobral M; MourĂ£o AF; Cavaleiro J; Ligeiro D; Abreu I; Carmo-Fonseca M; Branco JC Ann Rheum Dis; 2005 May; 64(5):793-4. PubMed ID: 15834068 [No Abstract] [Full Text] [Related]
11. The impact of pharmacogenetics on the development and use of antipsychotic drugs. Reynolds GP Drug Discov Today; 2007 Nov; 12(21-22):953-9. PubMed ID: 17993414 [TBL] [Abstract][Full Text] [Related]
15. Genetics of drug resistance. Sisodiya SM Epilepsia; 2005; 46 Suppl 10():33-8. PubMed ID: 16359469 [TBL] [Abstract][Full Text] [Related]
16. Confounding in genetic association studies and its solutions. Hu D; Ziv E Methods Mol Biol; 2008; 448():31-9. PubMed ID: 18370229 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Arranz MJ; de Leon J Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063 [TBL] [Abstract][Full Text] [Related]
18. The impact of microRNAs and alternative splicing in pharmacogenomics. Passetti F; Ferreira CG; Costa FF Pharmacogenomics J; 2009 Feb; 9(1):1-13. PubMed ID: 19156160 [No Abstract] [Full Text] [Related]
19. Pharmacogenetics of disease-modifying anti-rheumatic drugs. Tanaka E; Taniguchi A; Urano W; Yamanaka H; Kamatani N Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):233-47. PubMed ID: 15121042 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of multigenic disease: heart disease as an example. Cooke GE Vascul Pharmacol; 2006 Feb; 44(2):66-74. PubMed ID: 16376619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]